/Investor DB

Material Impact — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

Detrapeldetrapel.cominNov 2022 · $7.6M

DetraPel manufactures PFAS-free protective coatings and stain-repellent technologies for use in textiles, packaging, healthcare, and electronics.

Advanced ManufacturingCleantechNew MaterialsCharlotte, US

David Zamarin(Executive Officer, Director, Promoter)in

Board seatAdam Sharkawy· per SEC Form D

Co-investorsBacchus Venture CapitalBoro CapitalBoston Harbor AngelsCerity Partners VenturesFitz Gate VenturesIcebook Investments Corp.

NextGen Janenextgenjane.comin𝕏Jun 2022

NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples.

BiotechDigital HealthFemTechHealthtechOakland, US

Stephen Gire(Director)Ridhi Tariyal(Executive Officer, Director)in

Board seatAdam Sharkawy· per SEC Form D

Soft Robotics Inc.softroboticsinc.cominDec 2022

Soft Robotics Inc. rebranded as Oxipital AI after divesting its robotic gripper business to the Schmalz Group in August 2024, shifting its focus to machine vision inspection and defect detection technology.

Advanced ManufacturingAI & Machine LearningRoboticsBedford, US

Jeff Beck(Executive Officer, Director)in

BoardGeorge Whitesides(Director)inRory O'Driscoll(Director)inKevin Dunlap(Director)

Board seatAdam SharkawyCarmichael Roberts· per SEC Form D

Co-investorsIn-Q-TelTekfen VenturesCalibrate VenturesHoneywell VenturesHyperplane Venture CapitalScale Venture Partners

Huue Bioscienceshuue.bioinJul 2022 · $14.6M

Huue produces bio-based indigo dye for the denim industry using bioengineered microbes that convert sugar into pigment, replacing toxic chemical and petroleum-based processes.

BiotechCircular EconomyCleantech

Tammy Hsu(Principal Scientist & Co-Founder)in

BoardCorinna Chen(CEO)in

Co-investorsiGlobe PartnersSOSVVectors AngelPivotal Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.